Medicare Enrolled
Dr. James McCloskey, M.D.
Hematology · Hackensack, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. McCloskey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McCloskey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. McCloskey
Dr. James McCloskey is a hematology specialist in Hackensack, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. McCloskey performed 8,800 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. McCloskey received a total of $2,513,499 from 41 pharmaceutical and/or device companies across 1906 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. McCloskey is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 26% volume in NJ
$2,513,499 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗8,800
Medicare services
Top 26% in NJ for hematology
Not available
Unique patients (not deduplicated)
$30
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
6,680 | $6 | $41 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
493 | $146 | $301 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
473 | $102 | $217 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
458 | $107 | $239 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
243 | $74 | $154 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
137 | $12 | $76 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
67 | $148 | $420 |
| Bone marrow smear interpretation A laboratory review of a bone marrow sample slide to examine cell structure and identify abnormalities. |
60 | $61 | $332 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
40 | $68 | $155 |
| New patient office visit, complex (60-74 min) | 37 | $182 | $454 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
33 | $70 | $171 |
| Bone marrow aspiration A procedure to remove a small sample of liquid bone marrow for diagnostic testing. |
23 | $71 | $578 |
| Biopsy of bone marrow | 23 | $147 | $624 |
| Bone marrow biopsy and aspiration A procedure to remove a small sample of bone marrow and liquid for laboratory testing. The sample is analyzed to help diagnose various medical conditions. |
20 | $143 | $443 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
13 | $111 | $297 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$2,513,499
Total received (2018-2024)
Avg $359,071/year across 7 years
Top 2% in NJ for hematology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
41
Companies
1,906
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$608,974
2023
$420,485
2022
$383,379
2021
$192,837
2020
$240,495
2019
$339,648
2018
$327,680
Payments by company (2024)
GlaxoSmithKline, LLC.
$132,147
Takeda Pharmaceuticals U.S.A., Inc.
$106,542
Blueprint Medicines Corporation
$92,951
SOBI, INC
$59,784
E.R. Squibb & Sons, L.L.C.
$38,518
JAZZ PHARMACEUTICALS INC.
$36,137
PharmaEssentia USA Corporation
$30,789
Amgen Inc.
$30,343
Rigel Pharmaceuticals, Inc.
$23,344
Incyte Corporation
$19,605
Stemline Therapeutics Inc.
$19,404
Geron Corporation
$8,017
ABBVIE INC.
$5,483
Karyopharm Therapeutics Inc.
$2,575
TAIHO ONCOLOGY, INC.
$2,432
Celgene Corporation
$684
Daiichi Sankyo Inc.
$73
Novartis Pharmaceuticals Corporation
$50
Alexion Pharmaceuticals, Inc.
$31
Astellas Pharma US Inc
$19
PFIZER INC.
$16
Bard Peripheral Vascular, Inc.
$15
Adaptive Biotechnologies Corporation
$15
Top 3 companies account for 54.5% of 2024 payments
All-time payments by company (2018-2024) ›
Takeda Pharmaceuticals U.S.A., Inc.
$513,687
Celgene Corporation
$274,797
E.R. Squibb & Sons, L.L.C.
$229,133
Blueprint Medicines Corporation
$205,900
JAZZ PHARMACEUTICALS INC.
$149,837
GlaxoSmithKline, LLC.
$144,779
PharmaEssentia USA Corporation
$144,532
Jazz Pharmaceuticals Inc.
$132,650
Amgen Inc.
$122,254
Incyte Corporation
$120,483
Stemline Therapeutics Inc.
$107,435
CTI BioPharma Corp.
$84,111
Rigel Pharmaceuticals, Inc.
$60,788
Novartis Pharmaceuticals Corporation
$59,924
SOBI, INC
$59,784
PFIZER INC.
$28,379
AbbVie, Inc.
$16,139
Agios Pharmaceuticals, Inc.
$12,503
ABBVIE INC.
$10,658
Geron Corporation
$8,017
Gilead Sciences, Inc.
$7,250
TAIHO ONCOLOGY, INC.
$5,155
AbbVie Inc.
$4,275
Karyopharm Therapeutics Inc.
$2,575
Apellis Pharmaceuticals, Inc.
$2,360
NOVARTIS PHARMACEUTICALS CORPORATION
$1,995
Acceleron Pharma, Inc.
$1,690
Servier Pharmaceuticals LLC
$1,495
Alexion Pharmaceuticals, Inc.
$495
Daiichi Sankyo Inc.
$188
Otsuka America Pharmaceutical, Inc.
$48
Astellas Pharma US Inc
$37
GENZYME CORPORATION
$28
Genentech USA, Inc.
$20
Bard Peripheral Vascular, Inc.
$15
Spectrum Pharmaceuticals Inc.
$15
Merck Sharp & Dohme Corporation
$15
Adaptive Biotechnologies Corporation
$15
Pharmacyclics LLC, An AbbVie Company
$14
Foundation Medicine, Inc.
$12
Janssen Biotech, Inc.
$12
Top 3 companies account for 40.5% of all-time payments
Associated products mentioned in payments ›
AYVAKIT · BESPONSA · BESREMI · BOSULIF · Blincyto · DARZALEX · DAURISMO · ELITEK · ELZONRIS · EPKINLY · Empaveli · FOUNDATIONONE · Fabhalta · GLEEVEC · ICLUSIG · IDHIFA · INJECTAFER · INQOVI · INREBIC · Idhifa · Inrebic · JADENU · JAKAFI · LONSURF · MYLOTARG · Marqibo · NINLARO · NOXAFIL · Nplate · OJJAARA · ONUREG · Orserdu · Otezla · PROMACTA · REBLOZYL · RYDAPT · RYTELO · Reblozyl · Revlimid · Rezlidhia · SCEMBLIX · SOLIRIS · SPRYCEL · SYNAGIS · TASIGNA · TIBSOVO · Tavalisse · Trek · ULTOMIRIS · Ultomiris · VENCLEXTA · VONJO · VYXEOS · Vanflyta · Venclexta · Vonjo · XPOVIO · Xospata · clonoSEQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
132
County median income
$123,715
Nearest hospital to ZIP centroid (approximate)
HACKENSACK UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. McCloskey is a mixed practice specialist, with above-average Medicare volume (top 26% in NJ), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. McCloskey experienced with epoetin alfa injection (procrit) for anemia?
Based on Medicare claims data, Dr. McCloskey performed 6,680 epoetin alfa injection (procrit) for anemia services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. McCloskey receive payments from pharmaceutical companies?
Yes. Dr. McCloskey received a total of $2,513,499 from 41 companies across 1,906 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McCloskey's costs compare to other hematologists in Hackensack?
Dr. McCloskey's average Medicare payment per service is $30. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McCloskey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Hackensack
Browse hematologists in Hackensack ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in NJ
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in NJ
Which NJ hematologists receive the most from drug and device companies.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology